[Angioplasty in acute myocardial infarction in patients transferred from other hospitals]

A K Andreassen1, A Nanbjør, K Endresen

  • 1Hjertemedisinsk avdeling Rikshospitalet 0027 Oslo. arne.andreassen@rikshospitalet.no

Insights

Transferring acute myocardial infarction patients for primary or rescue angioplasty is feasible and safe. This study evaluated interhospital transport for interventional treatment, finding no severe complications and positive patient outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Emergency Medicine

Background:

  • Acute myocardial infarction (AMI) management often involves reperfusion therapies like primary or rescue angioplasty.
  • Initial diagnosis typically occurs at local hospitals, necessitating transfer for advanced interventional procedures.

Purpose of the Study:

  • To assess the feasibility and safety of interhospital transport for patients requiring angioplasty for AMI.
  • To compare outcomes between direct admission and interhospital transfer for primary and rescue angioplasty.

Main Methods:

  • A prospective observational study included 50 consecutive patients with AMI between January 1999 and April 2000.
  • Patients were categorized into direct primary angioplasty (n=20), transferred primary angioplasty (n=14), and transferred rescue angioplasty (n=16).
  • Key metrics included interhospital transport complications, time intervals, and left ventricular ejection fraction.

Main Results:

  • No severe complications were observed during interhospital transport.
  • While symptom-to-hospitalization times were similar, symptom-to-balloon inflation was significantly longer in the rescue angioplasty group (340 min vs. 130-181 min).
  • All patients survived follow-up (median 230 days), with comparable left ventricular ejection fractions across groups.

Conclusions:

  • Acute interhospital transfer for primary or rescue angioplasty is a feasible and safe strategy for selected AMI patients.
  • This approach enables timely reperfusion therapy in a tertiary care setting, even with initial diagnosis at local facilities.
Abstract

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...